One of this year’s hottest start-up companies is ‘Welt’ that developed health care wearable devices. 2 people that had worked for Samsung Electronics Co., Ltd. founded Welt. Because of CEO Kang Sung-ji’s unique career and his achievement, the wearable device using a belt for the first time in the world, he is in the spotlight.Welt is the combination of ‘Wellness’ and ‘Technology’, which shows
Officials at pharmaceutical companies think the election of Donald J Trump as the USA president is a ‘crisis’. It can’t be meaningful because only 46 people participated in the survey, but is meaningful in terms of perspective coming from officials in charge of international affairs.According to a mobile survey of ‘does Trump election affect Korean pharmaceutical companies?’ conducted by lawma
Hanmi Pharmaceutical Co., Ltd has been under controversy because the contract to export a new medicine was cancelled. Now, Hanmi is in trouble again because the a clinical test of the new medicine is postponed. Last November, the news that clinical test status of new bio medicine for diabetic and obesity, ‘HM12525A(JNJ-64565111’, had been changed to ‘suspended’ resulted from stopping clinical tes
Daehwa Pharmaceutical will export drugs to eleven countries in the Middle East and North Africa.On October 12, Daehwa Pharmaceutical announced that the company signed a contract with NOVOSCI, headquartered in the United Arab Emirates, to export drug products worth $20 million over a period of five years to eleven countries in the Middle East and North Africa including those under the jurisdict
The product license of the Sulbacillin injection, an antibiotic by Daewoong Pharmaceutical Company has been revoked. The company confirmed the contaminated injections, yet still did not take necessary measures, such as an immediate stop of sales or a recall.On August 8, the Ministry of Food and Drug Safety revoked the product license of Daewoong Pharmaceutical's 750mg and 1.5g Sulbacillin inje
Green Cross increased the domestic production facility for blood products, aiming to become the world's fifth in the production of blood products.Green Cross will complete the construction of a second plasma derivatives(PD) pipe, a facility to produce blood products, in its Ochang plant, and will soon test-run the facility for production.Blood products are drugs produced by deriving high-p
The possibility of Korea's new drug no. 15, Kanarb (active ingredient: Fimasartan), a hypertension drug, becoming a new global drug is growing.Boryung Pharmaceutical Company took part in a meeting of the International Society of Hypertension, one of the world's largest societies, held in Seoul until September 29 as the main sponsor and held a total of five satellite sessions, engraving Kanarb